Zacks Investment Research cut shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) from a hold rating to a sell rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha […]
Citigroup initiated coverage on shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) in a research report sent to investors on Monday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $21.00 target price on the stock. Separately, Zacks Investment Research downgraded shares of Alpha Tau Medical from a hold rating to […]